LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA
Clinical trials for LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Real-World data shows avelumab helps control advanced bladder cancer after chemo
Disease control CompletedThis study looked at 106 adults with advanced bladder cancer that hadn't gotten worse after initial chemotherapy. They received avelumab as a maintenance treatment to help keep the cancer under control. Researchers tracked how long patients lived and any side effects in real-worl…
Matched conditions: LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Bladder cancer treatment patterns under the microscope
Knowledge-focused CompletedThis study looks at how adults with advanced bladder cancer are treated in everyday medical practice, not in a controlled trial. Researchers will analyze data from cancer clinics to see how long patients go without their disease worsening after starting their first treatment. The…
Matched conditions: LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:39 UTC